Recent in Updates by Region (page 10 of 29)
Jan 23, 2012
China's State Food and Drug Administration (SFDA) sought comment regarding its recent organization of "special use cosmetics" into eight different categories. On Dec. 29, 2011, the SFDA published eight draft categories to obtain a hygienic license including: liquid, half solid, solid, cream or lotion, aerosol, organic solvent, ceryl-based and other.
Jan 5, 2012 | David C. Steinberg, Steinberg & Associates
Canada has had many regulatory changes to its chemicals, drugs and most recently, to its cosmetics. This column will discuss those regulatory changes, beginning with the most urgent. In addition, this column will highlight new comments published by Health Canada, in conjunction with Advertising Standards Canada, on acceptable and unacceptable cosmetic claims.
Jan 5, 2012 | To Yo Be, Contributing Author and Consultant
In Korea, cosmetics and related products such as foods, food additives and pharmaceuticals are regulated by the Korea Food and Drug Administration (KFDA). The Korean Cosmetic Products Act (KPCA), which was passed in 2000 to separate cosmetic and pharmaceutical regulations, categorizes cosmetic products into three major categories: general cosmetics; functional cosmetics, e.g., sunscreens and whitening products; and quasi drugs, e.g., anti-acne products.
Nov 21, 2011 | David C. Steinberg, Steinberg & Associates
Suppliers that export chemicals directly into Canada or that supply ingredients for finished products that are sold in Canada and, therefore, regulated under the Food and Drugs Act (F&DA) in Canada need to ensure that these substances are nominated to the revised In-Commerce List (ICL) in Canada.
EU Regulatory Update: The Individual Safety Assessment–a Practical Approach towards Regulation (EC) No 1223/2009
Oct 19, 2011 | Annelie Struessmann, PhD, CONUSBAT
The new Cosmetics Regulation (EC) No. 1223/2009 defined the format of the Cosmetic Product Safety Report (CPSR) in the Regulation’s Annex I. Accordingly, the information for documenting the product’s safety is to be listed in a part A of the CPSR, and this needs to include the toxicological profiles of the ingredient substances, their physical and chemical characteristics, impurities, trace components, as well as their exposure criteria in use.
Sep 14, 2011
Colipa, the European Cosmetics Association, welcomes the publication of the European Commission’s (EC) annual progress report on the development of alternative methods to animal testing for cosmetic purposes.
Sep 13, 2011
The Texas Department of State Health Services (DSHS) and South Texas Poison Control are warning consumers that Mexico-made skin cream Crema Aguamary may contain high levels of mercury.
Sep 8, 2011
The US Food and Drug Administration (FDA) has sent a warning letter to Brazilian Blowout for its Açai Professional Smoothing Solution. The FDA finds the product to be misbranded by stating on its label that it does not contain formaldehyde and is adulterated by containing methylene glycol, a liquid form of formaldehyde.
Aug 23, 2011 | Annelie Struessmann, PhD, CONUSBAT
In the EU, numerous mandates for new scientific opinions have been posted in 2011, with a specification of the assessment criteria and goals. The application areas mostly focus on the new and ongoing ingredient assessments of hair dyes, preservatives and UV filters.
Aug 22, 2011
The US Food and Drug Administration (FDA) has released Strategic Plan for Regulatory Science, its initiative to modernize the tools and methods that the agency uses to evaluate whether the products it regulates are safe for consumers.
Aug 3, 2011
Three global companies headquartered in the United States—Walmart, The Hershey Company and Citigroup—have become members of the Roundtable on Sustainable Palm Oil (RSPO), an organization that aims to promote the growth and use of sustainable palm oil in the world.
Jun 27, 2011
On June 24, 2011, Rep. Jan Schakowsky (D-IL) and 10 co-sponsors introduced the Safe Cosmetics Act of 2011 (H.R. 2359) to the US House of Representatives, which aims to amend title VI of the Federal Food, Drug and Cosmetic Act.